The role of talimogene laherparepvec (T-VEC) in the age of checkpoint inhibitors.
The role of talimogene laherparepvec (T-VEC) in the age of checkpoint inhibitors.
Clin Adv Hematol Oncol. 2016 Aug;14(8):576-9
Authors: Andtbacka RH
PMID: 27487099 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research
More News: Cancer & Oncology | Hematology